Business
1st patient dosed in AIPAC-003 ph2/3 breast cancer trial
1st patient dosed in AIPAC-003 ph2/3 breast cancer trial
About this update from Immutep Ltd
[{"type":"text","content":"Immutep Ltd has released a press release. View Attachment","length":223,"tagName":"div"}]